General Info

Abbott Molecular deals with molecular diagnostics business that provides physicians with critical information based on the early detection of pathogens and subtle changes in patients' genes and chromosomes. The company also practices for the selection of therapies and the monitoring of disease progression. It works in alliance with Celera Diagnostics to develop and market a range of next-generation molecular diagnostics products for unmet medical and laboratory needs. Abbott Molecular provides genomic tests for chromosome changes associated with congenital disorders and cancer, including the Vysis PathVysion HER-2 DNA Probe kit. It also offers Herceptin therapy and UroVysion, which detects genetic changes in bladder cells for use in monitoring bladder cancer recurrence in women with metastatic breast cancer.